Hyaluronate Targeted Solid Lipid Nanoparticles of Etoposide: Optimization and In Vitro Characterization

Table 4

Zeta potential of nontargeted and HA targeted SLNs of etoposide (𝑛=3).

Formulation code	Nontargeted (mV) ± SD	HA targeted (mV) ± SD
C2L1.5DO20	9.21±0.53	−3.82±0.65
C1L3SO20	10.86±0.73	−7.57±0.82
C1L3DO20	14.80±0.94	−8.25±0.78
C2L3DO10	10.10±0.46	−1.35±0.58
C1L3SO10	10.54±0.59	−7.29±0.75
C1L1.5SO10	12.00±0.42	−12.39±0.64
C1L1.5DO20	14.94±0.91	−13.74±0.98
C2L1.5SO20	6.56±0.86	−7.82±0.95
C1L1.5DO10	13.90±0.89	−12.68±0.92
C2L3DO20	9.02±0.38	−2.85±0.72
C2L3SO10	7.29±0.82	−2.21±0.96
C2L1.5SO10	8.30±0.65	−6.86±0.87